Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer

QR Code

Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer

Bibliographic Details
Main Authors:	Miles, D., Chan, Arlene, Dirix, L., Cortés, J., Pivot, X., Tomczak, P., Delozier, T., Sohn, J., Provencher, L., Puglisi, F., Harbeck, N., Steger, G., Schneeweiss, A., Wardley, A., Chlistalla, A., Romieu, G.
Format:	Journal Article
Published:	American Society of Clinical Oncology 2010
Online Access:	http://hdl.handle.net/20.500.11937/6136

Similar Items

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer
by: Miles, D., et al.
Published: (2013)

AVEREL: A Randomised Phase 111 Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER-2Positive Locally Recurrent/Metastatic Breast Cancer
by: Gianni, L., et al.
Published: (2013)

First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study
by: Bergh, J., et al.
Published: (2012)

Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2010)

Vomiting in docetaxel chemotherapy: which to blame, dose or gene?
by: Jabir, Rafid, et al.
Published: (2014)

Prevalence of Excessive Tearing in Women With Early Breast Cancer Receiving Adjuvant Docetaxel-Based Chemotherapy
by: Chan, Arlene, et al.
Published: (2013)

Biocompatible hyperbranched polyglycerol modified ß-cyclodextrin derivatives for docetaxel delivery
by: Xu, Z., et al.
Published: (2017)

Development and characterization of docetaxel and curcumin-loaded aerosolized nanoemulsion for pulmonary cancer
by: Asmawi, Azren Aida
Published: (2020)

Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer
by: De Boer, R., et al.
Published: (2012)

Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability
by: Badran, Mohamed M., et al.
Published: (2018)

Development and validation of HPLC method for quantification of docetaxel in palm-based nanoemulsion aerosols
by: Asmawi, Azren Aida, et al.
Published: (2020)

Nanostructured Lipid Carrier Co-Loaded with Docetaxel and Magnetic Nanoparticles: Physicochemical Characterization and In Vitro Evaluation
by: Auni Hamimi, Idris, et al.
Published: (2023)

Characterisation of tumorspheres generated from nasopharyngeal carcinoma cell line TW06 and chemoresistance to docetaxel
by: Goh, Iris Wen Li, et al.
Published: (2015)

In Vitro And In Vivo Toxicity Of Docetaxel-Loaded Polymeric Nanoparticles Formulation For Potential Treatment Of Lung Cancer
by: Ahmad Fisol, Faisalina
Published: (2022)

Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial.
by: Mackey, J., et al.
Published: (2016)

Excipient selection and aerodynamic characterization of nebulized lipid-based nanoemulsion loaded with docetaxel for lung cancer treatment
by: Asmawi, Azren Aida, et al.
Published: (2019)

Characterization of tumorspheres generated from nasopharyngeal carcinoma cell line, TW06 and chemoresistance to docetaxel and oxaliplatin
by: Goh, Iris Wen Li, et al.
Published: (2015)

Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epiderman growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial
by: Eiermann, W., et al.
Published: (2011)

Characterization, histological evaluation and efficacy of docetaxel-loaded cockle shellderived CaCO3 nanoparticles in vitro and in vivo
by: Hammadi, Nahidah Ibrahim
Published: (2018)

Phylosophy of science (plus ethics in research)
by: Rohana, Hamzah, et al.
Published: (2017)

Application of ASPEN PLUS in combustion modeling
by: Khoshnoodi, Mohammad
Published: (1995)

Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial
by: Cameron, David, et al.
Published: (2013)

Assessment in the service of learning: challenges and opportunities or Plus ça Change, Plus c’est la même Chose
by: Burkhardt, Hugh, et al.
Published: (2018)

Formulation of a sustained release docetaxel loaded cockle shell-derived calcium carbonate nanoparticles against breast cancer
by: Ibrahim Hammadi, Nahidah, et al.
Published: (2017)

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
by: Ford, Hugo, et al.
Published: (2014)

The Effects of Combination Treatment Using Phenoxodiol and Docetaxel, and Phenoxodiol and Secreted Frizzled-related Protein 4 on Prostate Cancer Cell Lines
by: Mahoney, S., et al.
Published: (2014)

Development and characterization of a theranostic micelles system using TPGS with docetaxel and coumarin-6: a dual polymeric nanocarrier system
by: Ching, L.H., et al.
Published: (2018)

HPC plus Azure Environment for Bioinformatics Applications
by: Sidhu, Amandeep, et al.
Published: (2013)

100 Plus promosi gaya hidup sihat
by: UMP, LIB
Published: (2016)

Emerald Management Xtra Plus Subscription 2009
by: Universiti Malaysia Sarawak, Centre for Academic Information Services
Published: (2009)

Designing swiftlet farming using energy plus
by: Frezzal, Faisal.
Published: (2009)

Isu PLUS kerajaan main tarik tali
by: Razib, Nabila Yasmin
Published: (2019)

Experimental validation of energyPlus simulation of a single storey building.
by: Baharun, A.
Published: (2011)

Plasma alpha-1-acid glycoprotein as a potential predictive biomarker for non-haematological adverse events of docetaxel in breast cancer patients
by: Jabir, Rafid Salim, et al.
Published: (2018)

Docetaxel-loaded magnetic nanostructured lipid carrier functionalized with fish oil-coated iron oxide nanoparticles intended for lung cancer treatment
by: Idris, Auni Hamimi
Published: (2021)

Liquid-liquid equilibrium of poly(ethylene glycol) 2000 plus potassium citrate plus water at (25, 35, and 45) degrees C
by: M., Jayapal, et al.
Published: (2007)

Liquid-liquid equilibrium of poly(ethylene glycol) 2000 plus potassium citrate plus water at (25, 35, and 45) degrees C
by: M., Jayapal, et al.
Published: (2007)

Sensitivity analysis of xylose production process using aspen plus
by: N H, Ibrahim, et al.
Published: (2020)

Asean plus guidelines: management of diabetic foot wounds
by: Soegondor, Sidartawan, et al.
Published: (2014)

Nanotechnology: radical new science or plus ça change?
by: Moriarty, Philip
Published: (2005)